SAT-362 Persistently Elevated Insulin-like Growth Factor-1 Levels Following Teprotumumab Treatment for Thyroid Eye Disease
G Schmidt(Maryland Oncology Hematology), Thanh D. Hoang(Walter Reed National Military Medical Center), Treyce Knee(Walter Reed National Military Medical Center), Sebastian C De La Torre(Walter Reed National Military Medical Center), Mohamed K M Shakir(Liaquat University of Medical & Health Sciences)
Cited by 1
Related Papers
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
|Journal of Diabetes Science and Technology|2022|288
Desiccated Thyroid Extract Compared With Levothyroxine in the Treatment of Hypothyroidism: A Randomized, Double-Blind, Crossover Study
|The Journal of Clinical Endocrinology & Metabolism|2013|152
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease
|Endocrinology and Metabolism Clinics of North America|2022|133
Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19
|Journal of King Saud University - Science|2020|121
MR evaluation of rotator cuff pathology using T2-weighted fast spin-echo technique with and without fat suppression.
|American Journal of Roentgenology|1996|109